CIK 0001583771 · Non-accelerated filer<br>Smaller reporting company
Hepion Pharmaceuticals, Inc.
Sign in to watch- Tickers
- HEPA CTRVP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462783806
- Phone
- 732-902-4000
- Business address
- 34 SHREWSBURY AVE., SUITE 1D, RED BANK, NJ, 07701
- Former names
- ContraVir Pharmaceuticals, Inc.
Securities
- HEPA Common stock OTC
- CTRVP Common stock OTC
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Executive or director change
- D Other Notice of Sales of Unregistered Securities
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Executive or director change · Regulation FD disclosure · Other events
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 10-K/A Report 10-K/A
Page 7 of 37 · 723 filings